Switching to Daily Doravirine/Islatravir (100/0.25 mg) Maintains Viral Suppression Through Week 48 Despite Baseline Non-Nucleoside Reverse Transcriptase Inhibitor Resistance-Associated Mutations or M184I/V in Proviral DNA. (academic.oup.com)

Authors: Diamond TL … Asante-Appiah E Journal: Journal of Infectious Diseases Published: 2026-05-29 DOI: https://doi.org/10.1093/infdis/jiag257